期刊文献+

含三磷酸腺苷的复方麻黄素滴鼻制剂对纤毛运动影响的初步探讨 被引量:2

Preliminary study on the effect of compound ephedrine nasal drops containing ATP on ciliary movement
下载PDF
导出
摘要 目的 探讨三磷酸腺苷 (ATP)对麻黄素滴鼻制剂对纤毛运动的影响。方法 以离体蟾蜍上腭黏膜为模型 ,研究 1%麻黄素、复方麻黄素、ATP及含ATP的复方麻黄素滴鼻制剂对纤毛运动的影响。结果  4种滴鼻制剂与生理盐水的相对纤毛运动时间持续百分率分别为 :1%麻黄素为 91 8% ,复方麻黄素为 4 2 8% ,ATP为 110 5 % ,含ATP的复方麻黄素制剂为 87 7%。结论 复方麻黄素滴鼻剂对纤毛毒性较大 。 Objective To investigate the effect of compound ephedrine nasal drops on the ciliary movement.Methods Using toad palate as model in vitro, the effect on ciliary movement was studied for 1% ephedrine, compound ephedrine,ATP,and compound ephedrine containing ATP.Results The relative percentage of the lasting time of ciliary movement of the four nasal drops compared with normal saline:1% ephedrine was 91.8%, compound ephedrine was 42.8%, ATP was 110.5% and compound ephedrine containing ATP was 87.7%.Conclusion Ciliotoxcity of compound ephedrine is distinct relatively, but it can be reduced by ATP.
作者 许卫华
出处 《山西医药杂志》 CAS 2004年第4期305-306,共2页 Shanxi Medical Journal
关键词 三磷酸腺苷 复方麻黄素滴鼻制剂 纤毛运动 纤毛毒性 Adenosine triphosphate Ephedrine Ciliary movement Ciliotoxicity
  • 相关文献

参考文献6

  • 1夏运岳,金鸿宾,陈幼亭.4种滴鼻剂对蛙口腔粘膜纤毛运动的影响[J].中国临床药学杂志,1998,7(5):228-230. 被引量:5
  • 2Ohashi Y, Nakai Y, Ikeoka H,et al. Regeneration of nasal mucosa following mechanical injury.Acta Otolaryngol,1991,486(Suppl):193-201.
  • 3Donk HJM,Merkus FWHM.Decreases in ciliary beat frequency due to intranasal administration of propranolol.J Pharm Sci,1982,71:595.
  • 4Hisamatsu K,Yamauchi Y,Uchida M,et al.Promotive effect of lysozyme on the ciliary activity of the human nasal mucosa. Acta Otolaryngol,1986,101:290.
  • 5毋哲生 傅金聚 石丽亚.实验性药物性鼻炎扫描电镜观察[J].中华耳鼻咽喉科杂志,1990,25(1):53-53.
  • 6许庚,顾之燕,韩德民,黄维国,杨占泉,孔维佳,梁传余,林尚泽,叶非常,陈合新,文卫平,史剑波.关于限制滥用麻黄素类鼻腔减充血剂的建议[J].耳鼻咽喉(头颈外科),2003,10(3):186-188. 被引量:27

二级参考文献10

  • 1蒋新国,崔景斌,方晓玲,韦阳,奚念朱.药物的鼻粘膜纤毛毒性及评价方法[J].药学学报,1995,30(11):848-853. 被引量:86
  • 2[4]Jackson RT. Mechanism of action of some commonly used drugs. Otolaryngol Head Neck Surg. 1991 ; 104: 433- 440.
  • 3[7]Black MJ Remsen KA. Rhinitis medicamentosa. Can Med Assoc J. 1980;122:881-884.
  • 4[8]Ohashi Y,Nakai Y,Ikeoka H,et al. Regeneration of nasal mucosa following mechanical injury. Acta Otolaryngol.1991; (Suppl 486): 193- 201.
  • 5[9]Graf PM. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nsaal spray. ORL. 1998 ; 60: 334- 338.
  • 6[11]Graf PM. Overruse of oxy-and xylometazoline nasal sprays. Changes in nasal mucosal swelling and histamine sensitivity in healthy subjects and patients with rhinitsis medicamentosa. Thesis paper. Karolinska Institute, Sweden, 1994 ;ISBN 91-628-1395-1
  • 7[12]Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol. 1993 ; 45 (Suppl): 3-7.
  • 8[13]Meltzer EO,Jalowayski AA,Orgel HA,et al. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol. 1998 ; 102: 39- 49.
  • 9[14]Stierna P,Jannert M. Current opinions on the pathogenesis of sinusitis. Acta Otolaryngol. 1994; (Suppl 515):1-64.
  • 10[15]Stierna P, Soderlund K,Carlsoo B. The source of lactic acid in experimental sinusitis in rabbits. Am J Rhinol.1992;6:111-113.

共引文献36

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部